-
Immune-Onc and UT System to develop new biotherapeutics for cancer immunotherapy
pharmaceutical-technology
April 11, 2017
Immune-Onc Therapeutics has entered an agreement with two member institutions of the University of Texas System (UT ...
-
Antibiotics overuse could boost bowel cancer risk
pharmatimes
April 07, 2017
Long-term use of antibiotics can significantly raise the risk of developing polyps on the bowel that can lead to cancer...
-
Speedy review for BMS’ Opdivo in colorectal cancers
pharmatimes
April 07, 2017
The US Food and Drug Administration will undertake a priority review of Bristol-Myers Squibb’s immunotherapy Opdivo as ...
-
ICR scientists uncover information about genetic causes of brain cancer
pharmaceutical-technology
March 29, 2017
A new brain cancer study conducted by scientists at London's Institute of Cancer Research (ICR) has revealed new secrets about the genetic causes of the disease.
-
A computer program for diagnosing and locating cancer
biospectrumasia
March 28, 2017
A computer program has been developed by a team of researchers at the University of California for detecting and identifying the location of cancer within the patient's body.
-
Merck and Pfizer secure US FDA approval for Bavencio to treat skin cancer
pharmaceutical-technology
March 28, 2017
Merck’s biopharmaceutical business EMD Serono and Pfizer have obtained the US Food and Drug Administration’s (FDA) approval for a 20mg/mL Bavencio (avelumab) injection to treat ...
-
Leukaemia CARE’s research finds inequalities in cancer care for elderly patients
pharmaceutical-technology
March 28, 2017
UK charity Leukaemia CARE has conducted new research into the lives of older people living with blood cancers and revealed inequalities in cancer care for elderly patients compared with ...
-
Contraceptive pill reduces cancer risk long-term, study finds
pharmatimes
March 23, 2017
Women who have taken the oral contraceptives seem have a reduced risk of developing some types of cancer for as ...
-
Ferrier Research Institute and BCFNZ to create new breast cancer vaccine
pharmaceutical-technology
March 23, 2017
Victoria University of Wellington's Ferrier Research Institute and the Breast Cancer Foundation New Zealand (BCFNZ) ...
-
Pierre Fabre and H-Immune to develop new cancer immunotherapies
pharmaceutical-technology
March 23, 2017
French pharmaceutical company Pierre Fabre and H-Immune have entered a strategic research partnership to develop ...